Clinical Trials Directory

Trials / Completed

CompletedNCT07466654

Low-Dose Caffeine and Taurine Effects on Performance

Synergistic Effects of Low-Dose Caffeine and Taurine on Anaerobic, Neuromuscular, and Cognitive Performance: A Double-Blind Randomized Placebo-Controlled Crossover Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
32 (actual)
Sponsor
Ankara University · Academic / Other
Sex
Male
Age
18 Years – 25 Years
Healthy volunteers
Not accepted

Summary

This study aims to investigate the effects of low-dose caffeine and taurine, administered separately and in combination, on anaerobic, neuromuscular, and cognitive performance. The study is designed as a randomized, double-blind, placebo-controlled crossover trial involving trained man participants. Each participant will complete experimental sessions under different supplementation conditions, including caffeine, taurine, their combination, and placebo. Performance outcomes will include anaerobic power, neuromuscular performance, and cognitive function assessments. The findings will help clarify whether the combined ingestion of caffeine and taurine produces synergistic performance effects compared with isolated supplementation.

Detailed description

Caffeine and taurine are commonly consumed ingredients in coffee and energy drinks and are frequently used as ergogenic aids to enhance physical and cognitive performance. Although both compounds have been widely investigated individually, evidence regarding their combined effects remains limited and inconsistent. Understanding whether caffeine and taurine produce synergistic or additive effects is important for clarifying their role in sports performance and supplementation strategies. The present study is designed as a randomized, double-blind, placebo-controlled crossover trial to examine the isolated and combined effects of low-dose caffeine and taurine on anaerobic, neuromuscular, and cognitive performance in trained individuals. Participants will complete multiple experimental sessions under different supplementation conditions, including caffeine, taurine, their combination, and placebo. During each session, participants will undergo standardized performance assessments to evaluate anaerobic power, neuromuscular performance, and cognitive function. The crossover design allows each participant to serve as their own control, minimizing inter-individual variability. The findings of this study may provide further insight into the potential synergistic effects of caffeine and taurine supplementation on performance outcomes.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTCaffeineCaffeine administered at a dose of 2 mg/kg body mass in capsule form, 60 minutes prior to performance testing.
DIETARY_SUPPLEMENTtaurineTaurine administered at a dose of 10 mg/kg body mass in capsule form, 60 minutes prior to performance testing.
DIETARY_SUPPLEMENTCaffeine + TaurineCombined supplementation of caffeine (2 mg/kg) and taurine (10 mg/kg) administered 60 minutes prior to testing.
DIETARY_SUPPLEMENTPlaceboPlacebo capsule containing maltodextrin (300 mg) administered 60 minutes prior to testing.

Timeline

Start date
2025-10-15
Primary completion
2025-11-15
Completion
2025-11-15
First posted
2026-03-12
Last updated
2026-03-12

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT07466654. Inclusion in this directory is not an endorsement.